Safety Study of an Antimicrobial Peptide Lactocin 160, Produced by the Vaginal Lactobacillus rhamnosus
2007
Safety Study of Lactocin 160 from Lactobacillus rhamnosus
Sample size: 6
publication
Evidence: moderate
Author Information
Author(s): Sara E. Dover, Alla A. Aroutcheva, S. Faro, Michael L. Chikindas
Hypothesis
To evaluate the safety of the antimicrobial peptide, lactocin 160.
Conclusion
Lactocin 160 showed minimal irritation and has a good potential for intravaginal application.
Supporting Evidence
- Lactocin 160 had an ET-50 value of 17.5 hours, indicating low toxicity.
- The hemolytic activity of lactocin 160 was only 8.2%, much lower than the total hemolysis caused by nonoxynol-9.
- Three-dimensional EpiVaginal tissue model showed similar results to in vivo testing.
Takeaway
Lactocin 160 is a substance made by good bacteria that helps keep the vagina healthy and doesn't cause irritation.
Methodology
In vitro and in vivo testing using EpiVaginal tissue model and rabbit vaginal irritation model.
Limitations
The study may not fully represent human responses due to differences between rabbit and human vaginal tissue.
Participant Demographics
Healthy female rabbits were used for the in vivo model.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website